SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Micrologix biotech

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Graham Dellaire who wrote (743)9/19/2000 6:59:44 PM
From: Larry G.  Read Replies (2) of 792
 
Hi Graham,

Micrologix is going to announce that they have started phase 3 on MBI 226. This should be before September 30. They will release details with press release. I have talked to PR at Micrologix, he seems very happy but says he can not say a thing till the news is released.

I think this will be major news release.

In fourth quarter Micrologix will announce starting phase two for other two drugs.

Other news releases may come.

At the annual meeting Hadary talked about an agreement with a major pharma concerning MBI 226. He said it will come next year.

Ussually September and November are bad months for stocks but in September, MBI has moved up 36 percent.

Things look good. I hope you picked up some more stock. I was buying till $5.50 and then I stopped. I have 60 to 70% of my money in MBI. I should not buy any more. Next run up I think I should do some profit taking.

Good luck
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext